Beyond steroidogenesis: Novel target genes for SF-1 discovered by genomics

Molecular and Cellular Endocrinology

Volumn 371, Issue 1-2, 2013, Pages 154-159

  Lalli, Enzo ^a,b   Doghman, Mabrouka ^a,b   Latre de Late, Perle ^a,b   El Wakil, Abeer ^a,b   Mus Veteau, Isabelle ^a,b  

^a CNRS   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Adrenal cortex; Genomics; HPA axis; Nuclear receptors; SF 1; Transcription factors; VMH

Indexed keywords

MICRORNA 125B; STEROIDOGENIC FACTOR 1;

ADRENAL CORTEX TUMOR; ADRENAL DISEASE; AMINO ACID SUBSTITUTION; APOPTOSIS; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENOMICS; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; STEROIDOGENESIS;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; APOPTOSIS; CELL ADHESION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE DOSAGE; GENE EXPRESSION REGULATION; GENOMICS; GONADS; HUMANS; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; STEROIDOGENIC FACTOR 1; STEROIDS;

EID: 84876079350     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.11.005     Document Type: Review

References (56)

1. Achermann J.C., Ito M., Ito M., Hindmarsh P.C., Jameson J.L. A mutation in the gene encoding Steroidogenic Factor-1 causes XY sex reversal and adrenal failure in humans. Nature Genetics 1999, 22:125-126.
2. Achermann J.C., Ozisik G., Ito M., Orun U.A., Harmanci K., Gurakan B., Jameson J.L. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor Steroidogenic Factor-1, in a dose-dependent manner. Journal of Clinical Endocrinology and Metabolism 2002, 87:1829-1833.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Bashamboo A., Ferraz-de-Souza B., Lourenço D., Lin L., Sebire N.J., Montjean D., Bignon-Topalovic J., Mandelbaum J., Siffroi J.P., Christin-Maitre S., Radhakrishna U., Rouba H., Ravel C., Seeler J., Achermann J.C., McElreavey K. Human male infertility associated with mutations in NR5A1 encoding Steroidogenic Factor 1. American Journal of Human Genetics 2010, 87:505-512.
5. Bassett M.H., Zhang Y., Clyne C., White P.C., Rainey W.E. Differential regulation of aldosterone synthase and 11β-hydroxylase transcription by Steroidogenic Factor-1. Journal of Molecular Endocrinology 2002, 28:125-135.
6. Beuschlein F., Mutch C., Bavers D.L., Ulrich-Lai Y.M., Engeland W.C., Keegan C., Hammer G.D. Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology 2002, 143:3122-3135.
7. Biason-Lauber A., Schoenle E.J. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive Steroidogenic Factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. American Journal of Human Genetics 2000, 67:1563-1568.
8. Bland M.L., Jamieson C.A., Akana S.F., Bornstein S.R., Eisenhofer G., Dallman M.F., Ingraham H.A. Haploinsufficiency of Steroidogenic Factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proceedings of the National Academy of Sciences of the United States of America. 2000, 97:14488-14493.
9. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America. 2004, 101:2999-3004.
10. Crawford P.A., Sadovsky Y., Milbrandt J. Nuclear receptor Steroidogenic Factor 1 directs embryonic stem cells toward the steroidogenic lineage. Molecular and Cellular Biology 1997, 17:3997-4006.
11. Doghman M., Karpova T., Rodrigues G.A., Arhatte M., De Moura J., Cavalli L.R., Virolle V., Barbry P., Zambetti G.P., Figueiredo B.C., Heckert L.L., Lalli E. Increased Steroidogenic Factor-1 dosage triggers adrenocortical cell proliferation and cancer. Molecular Endocrinology 2007, 21:2968-2987.
12. Doghman M., Arhatte M., Thibout H., Rodrigues G., De Moura J., Grosso S., West A., Laurent M., Mas J.C., Bongain A., Zambetti G.P., Figueiredo B.C., Auberger P., Martinerie C., Lalli E. NOV/CCN3, a selective adrenocortical cell pro-apoptotic factor, is downregulated in childhood adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 2007, 92:3253-3260.
13. Doghman M., El Wakil A., Cardinaud B., Thomas E., Wang J., Zhao W., Peralta Del Valle M.H.C., Figueiredo B.C., Zambetti G.P., Lalli E. Regulation of insulin-like growth factor - mammalian target of rapamycin signaling by microrna in childhood adrenocortical tumors. Cancer Research 2010, 70:4666-4675.
14. Ehrlund A., Holter Anthonisen E., Gustafsson N., Venteclef N., Robertson Remen K., Damdimopoulos A.E., Galeeva A., Pelto-Huikko M., Lalli E., Steffensen K.R., Gustafsson J.å., Treuter E. The E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis. Molecular and Cellular Biology 2009, 29:2230-2242.
15. Ehrlund A., Jonsson P., Vedin L.L., Williams C., Gustafsson J.å., Treuter E. Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFβ, and Wnt/β-catenin signaling in adrenocortical carcinoma cells. PLoS ONE 2012, 7:e32080.
16. El Wakil A., Lalli E. The Wnt/beta-catenin pathway in adrenocortical development and cancer. Molecular and Cellular Endocrinology 2011, 332:32-37.
17. Fatchiyah, Zubair M., Shima Y., Oka S., Ishihara S., Fukui-Katoh Y., Morohashi K. Differential gene dosage effects of Ad4BP/SF-1 on target tissue development. Biochemical and Biophysical Research Communications 2006, 341:1036-1045.
18. Feige J.J., Vilgrain I., Brand C., Bailly S., Souchelnitskiy S. Fine tuning of adrenocortical functions by locally produced growth factors. Journal of Endocrinology 1998, 158:7-19.
19. Feige J.J. Angiogenesis in adrenocortical physiology and tumor development. Annales d'Endocrinologie 2009, 70:153-155.
20. Ferraz-de-Souza B., Lin L., Shah S., Jina N., Hubank M., Dattani M.T., Achermann J.C. ChIP-on-chip analysis reveals angiopoietin 2 (Ang2, ANGPT2) as a novel target of Steroidogenic Factor-1 (SF-1, NR5A1) in the human adrenal gland. FASEB Journal 2011, 25:1166-1175.
21. Ferraz-de-Souza B., Hudson-Davies R.E., Lin L., Parnaik R., Hubank M., Dattani M.T., Achermann J.C. Sterol-O-acyltransferase 1 (SOAT1, ACAT) is a novel target of Steroidogenic Factor-1 (SF-1, NR5A1, Ad4BP) in the human adrenal. Journal of Clinical Endocrinology and Metabolism 2011, 96:E663-E668.
22. Figueiredo B.C., Cavalli L.R., Pianovski M.A., Lalli E., Sandrini R., Ribeiro R.C., Zambetti G., DeLacerda L., Rodrigues G.A., Haddad B.R. Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumours. Journal of Clinical Endocrinology and Metabolism 2005, 90:615-619.
23. Garzon R., Fabbri M., Cimmino A., Calin G.A., Croce C.M. MicroRNA expression and function in cancer. Trends in Molecular Medicine 2006, 12:580-587.
24. Hoivik E.A., Lewis A.E., Aumo L., Bakke M. Molecular aspects of Steroidogenic Factor 1 (SF-1). Molecular and Cellular Endocrinology 2010, 315:27-39.
25. Ikeda Y., Lala D.S., Luo X., Kim E., Moisan M.P., Parker K.L. Characterization of the mouse FTZ-F1 gene, which encodes a key regulator of steroid hydroxylase gene expression. Molecular Endocrinology 1993, 7:852-860.
26. Ikeda Y., Luo X., Abbud R., Nilson J.H., Parker K.L. The nuclear receptor Steroidogenic Factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Molecular Endocrinology 1995, 9:478-486.
27. Johnsen I.K., Beuschlein F. Role of bone morphogenetic proteins in adrenal physiology and disease. Journal of Molecular Endocrinology 2010, 44:203-211.
28. Jun J.I., Lau L.F. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nature Reviews Drug Discovery 2011, 10:945-963.
29. Lala D.S., Rice D.A., Parker K.L. Steroidogenic Factor-I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of Fushi tarazu-factor I. Molecular Endocrinology 1992, 6:1249-1258.
30. Lalli E., Sassone-Corsi P. DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Molecular Endocrinology 2003, 17:1445-1453.
31. Lalli E. Adrenocortical development and cancer: focus on SF-1. Journal of Molecular Endocrinology 2010, 44:301-307.
32. Letouzé E., Rosati R., Komechen H., Doghman M., Marisa L., Flück C., de Krijger R.R., van Noesel M.M., Mas J.-C., Pianovski M.A.D., Zambetti G.P., Figueiredo B.C., Lalli E. SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes. Journal of Clinical Endocrinology and Metabolism 2012, 97:E1284-E1293.
33. Li X., Shen Y., Ichikawa H., Antes T., Goldberg G.S. Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration. Oncogene 2009, 28:4272-4283.
34. Lin L., Philibert P., Ferraz-de-Souza B., Kelberman D., Homfray T., Albanese A., Molini V., Sebire N.J., Einaudi S., Conway G.S., Hughes I.A., Jameson J.L., Sultan C., Dattani M.T., Achermann J.C. Heterozygous missense mutations in Steroidogenic Factor 1 (SF1/Ad4BP, NR5A1) are associated with 46, XY disorders of sex development with normal adrenal function. Journal of Clinical Endocrinology and Metabolism 2007, 92:991-999.
35. Lourenço D., Brauner R., Lin L., De Perdigo A., Weryha G., Muresan M., Boudjenah R., Guerra-Junior G., Maciel-Guerra A.T., Achermann J.C., McElreavey K., Bashamboo A. Mutations in NR5A1 associated with ovarian insufficiency. New England Journal of Medicine 2009, 360:1200-1210.
36. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77:481-490.
37. Luo X., Ikeda Y., Schlosser D.A., Parker K.L. Steroidogenic Factor 1 is the essential transcript of the mouse Ftz-F1 gene. Molecular Endocrinology 1995, 9:1233-1239.
38. Martinerie C., Gicquel C., Louvel A., Laurent M., Schofield P.N., Le Bouc Y. Altered expression of novH is associated with human adrenocortical tumorigenesis. Journal of Clinical Endocrinology and Metabolism 2001, 86:3929-3940.
39. Morohashi K., Honda S., Inomata Y., Handa H., Omura T. A common transacting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. Journal of Biological Chemistry 1992, 267:17913-17919.
40. Morohashi K., Tsuboi-Asai H., Matsushita S., Suda M., Nakashima M., Sasano H., Hataba Y., Li C.L., Fukata J., Irie J., Watanabe T., Nagura H., Li E. Structural and functional abnormalities in the spleen of an mFtz-F1 gene-disrupted mouse. Blood 1999, 93:1586-1594.
41. Parker K.L., Rice D.A., Lala D.S., Ikeda Y., Luo X., Wong M., Bakke M., Zhao L., Frigeri C., Hanley N.A., Stallings N., Schimmer B.P. Steroidogenic Factor 1: an essential mediator of endocrine development. Recent Progress in Hormone Research 2002, 57:19-36.
42. Pianovski M.A., Cavalli L.R., Figueiredo B.C., Santos S.C., Doghman M., Ribeiro R.C., Oliveira A.G., Michalkiewicz E., Rodrigues G.A., Zambetti G., Haddad B.R., Lalli E. SF-1 overexpression in childhood adrenocortical tumours. European Journal of Cancer 2006, 42:1040-1043.
43. Ratcliffe J., Nakanishi M., Jaffe R.B. Identification of definitive and fetal zone markers in the human fetal adrenal gland reveals putative developmental genes. Journal of Clinical Endocrinology and Metabolism 2003, 88:3272-3277.
44. Rui X., Tsao J., Scheys J.O., Hammer G.D., Schimmer B.P. Contributions of Specificity Protein-1 and Steroidogenic Factor 1 to Adcy4 expression in Y1 mouse adrenal cells. Endocrinology 2008, 147:2357-2367.
45. Sadovsky Y., Crawford P.A., Woodson K.G., Polish J.A., Clements M.A., Tourtellotte L.M., Simburger K., Milbrandt J. Mice deficient in the orphan receptor Steroidogenic Factor 1 lack adrenal glands and gonads but express P450 sidechain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proceedings of the National Academy of Sciences of the United States of America. 1995, 92:10939-10943.
46. Schimmer B.P., White P.C. Minireview: Steroidogenic Factor 1: its roles in differentiation, development, and disease. Molecular Endocrinology 2010, 24:1322-1337.
47. Schimmer B.P., Tsao J., Cordova M., Mostafavi S., Morris Q., Scheys J.O. Contributions of Steroidogenic Factor-1 to the transcription landscape of Y1 mouse adrenocortical tumor cells. Molecular and Cellular Endocrinology 2011, 336:85-91.
48. Shinoda K., Lei H., Yoshii H., Nomura M., Nagano M., Shiba H., Sasaki H., Osawa Y., Ninomiya Y., Niwa O., Morohashi K.I., Li E. Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Developmental Dynamics 1995, 204:22-29.
49. Staels B., Hum D.W., Miller W.L. Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal. Molecular Endocrinology 1993, 7:423-433.
50. Tanaka T., Gondo S., Okabe T., Ohe K., Shirohzu H., Morinaga H., Nomura M., Tani K., Takayanagi R., Nawata H., Yanase T. Steroidogenic Factor 1/Adrenal 4 binding protein transforms human bone marrow mesenchymal cells into steroidogenic cells. Journal of Molecular Endocrinology 2007, 39:343-350.
51. Wagner W., Horn P., Castoldi M., Diehlmann A., Bork S., Saffrich R., Benes V., Blake J., Pfister S., Eckstein V., Ho A.D. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE 2008, 3:e2213.
52. West A.N., Neale G.A., Pounds S., Figueiredo B.C., Galindo C.R., Pianovski M.A.D., Oliveira Filho A.G., Malkin D., Lalli E., Ribeiro R., Zambetti G.P. Gene expression profiling of childhood adrenocortical tumors. Cancer Research 2007, 67:600-608.
53. Williams T.A., Monticone S., Crudo V., Warth R., Veglio F., Mulatero P. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis. Hypertension 2012, 59:833-839.
54. Wilson T.E., Fahrner T.J., Milbrandt J. The orphan receptors NGFI-B and Steroidogenic Factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Molecular and Cellular Biology 1993, 13:5794-5804.
55. Ye P., Nakamura Y., Lalli E., Rainey W. Differential effects of high and low Steroidogenic Factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. Endocrinology 2009, 150:1303-1309.
56. Yin M., Lü M., Yao G., Tian H., Lian J., Liu L., Liang M., Wang Y., Sun F. Transactivation of microRNA-383 by Steroidogenic factor-1 promotes estradiol release from mouse ovarian granulosa cells by targeting RBMS1. Molecular Endocrinology 2012, 26:1129-1143.